Abstract |
Prostaglandin A1 is a potent hypotensive, peripheral vasodilator, a weak oxytocic, antiplatelet aggregator. It improves the renal hemodynamics. Its effect on placental circulation was evaluated (expressed as systolic/diastolic ratio and umbilical artery resistance index) in 20 women with severe pre-eclampsia and 10 normotensive pregnant women, by using the Doppler technique. Moreover, another 10 women with severe pre-eclampsia received dextrose 5% as a placebo for comparative purposes. Significant improvements in both parameters studied were observed in the women with severe pre-eclampsia. The beneficial changes differed significantly from the recorded values when using dextrose in pre-eclampsia or prostaglandin A1 in normotensive subjects. Such promising data add another important perspective to prostaglandin A1 in severe pre-eclampsia and may open up new avenues for its use in other situations with compromised placental flow.
|
Authors | M Toppozada, I Medhat, H Sallam, A A Ismail, E S el-Badawy, S Abd Rabbo |
Journal | Acta obstetricia et gynecologica Scandinavica
(Acta Obstet Gynecol Scand)
Vol. 71
Issue 1
Pg. 22-7
(Jan 1992)
ISSN: 0001-6349 [Print] United States |
PMID | 1315092
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Blood Pressure
(drug effects)
- Diastole
(drug effects)
- Female
- Fetus
(blood supply)
- Humans
- Placenta
(blood supply)
- Pre-Eclampsia
(drug therapy, physiopathology)
- Pregnancy
- Prostaglandins A
(therapeutic use)
- Regional Blood Flow
- Systole
(drug effects)
- Ultrasonography, Prenatal
- Umbilical Arteries
(physiology)
- Vascular Resistance
(drug effects)
|